Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Yael L. Maxwell

March 26, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

Advertisement

Top General Cardiology and Prevention News of 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Semaglutide May Ease Tobacco Use, Study Suggests

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content